ImmuCell Corporation (ICCC)

NASDAQ
8.090
+0.030(+0.37%)
  • Volume:
    762
  • Day's Range:
    8.090 - 8.140
  • 52 wk Range:
    7.300 - 10.960

ICCC Overview

Prev. Close
8.06
Day's Range
8.09-8.14
Revenue
20.46M
Open
8.14
52 wk Range
7.3-10.96
EPS
0.035
Volume
762
Market Cap
62.67M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
7,774
P/E Ratio
230.83
Beta
0.584
1-Year Change
-10.54%
Shares Outstanding
7,746,864
Next Earnings Date
-
What is your sentiment on ImmuCell?
or
Vote to see community's results!

ImmuCell Corporation News

Welcome to Your News Upgrade

Be the First to Know and Act on Market Moving News.

Welcome to Your News Upgrade
  • Healthcare - Top 5 Gainers / Losers as of 11:00 am
    • BySeeking Alpha-

    Gainers: LENS +136%. PFNX +55%. CERC +18%. RIOT +16%. CANF +15%.Losers: NVAX -18%. ICCC -16%. EYES -8%. TRXC -7%. BLPH -7%.Now read: Concert Pharma (CNCE) Presents At Jefferies...

  • Midday Gainers / Losers
    • BySeeking Alpha-

    Gainers: CRDS +25%. XPLR +14%. HLG +14%. SYPR +13%. DRYS +12%. EXTR +12%. CVO +12%. OTIC +11%. WPRT +11%. FBIO +10%.Losers: AAP -22%. DKS -21%. TEAR -20%. CGIX -19%. TCCO -19%....

ImmuCell Corporation Company Profile

ImmuCell Corporation Company Profile

Employees
0

ImmuCell Corporation is an animal health company. The Company is engaged in development, acquisition, manufacture and sale of products that improve the health and productivity of dairy and beef cattle. It manufactures and markets the First Defense product line for the prevention of scours in newborn dairy and beef calves. It expanded this line into five different products with formulations targeting E. coli and coronavirus pathogens, as well as E. coli, coronavirus and rotavirus pathogens. Its Tri-Shield First Defense product line extension is calf-level, passive antibody product providing immediate immunity against E. coli, coronavirus and rotavirus. These product line provides Immediate Immunity to newborn calves. The Company is engaged in development of Re-Tain, a Nisin treatment for subclinical mastitis in lactating dairy cows. Its products reduce the use of traditional antibiotics in food producing animals.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesNeutralSellSellStrong SellNeutral
Technical IndicatorsBuyStrong SellStrong SellStrong SellSell
SummaryNeutralStrong SellStrong SellStrong SellNeutral